Abiopharma

🔍 Watts Stanfield Paris (Executive)

Company: IDEX CORP /DE/ (IEX)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 805 shares of COMMON STOCK (Direct)
  Date: 2026-05-06 | Code: A | equity_swap_involved: false | shares_owned_after: 4,195.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs vest in full on the earlier of May 6, 2027, and the date of the Issuer's next annual stockholders meeting if it is at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continuous service through such date.